ArticleRadiology advances2024
Pulmonary embolism detection without intravenous contrast using electron density and Z-effective maps from dual-energy CT.
Article in Radiology advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aims to evaluate the feasibility of using electron density (ED) maps combined with Z-effective (Zeff) images obtained from unenhanced dual-layer dual-energy CT (dl-DECT) scans of the chest for the detection of pulmonary embolism (PE). Materials and methods: A retrospective analysis was conducted on consecutive patients who underwent for contrast-enhanced chest CT (CECT) clinically suspected of PE or acute aortic syndrome. These scans were performed on a single dl-DECT scanner between October 2021 and November 2023. To distinguish emboli from circulating blood, color-coded maps were generated from the ED dataset superimposed on Zeff images, which were acquired from the unenhanced phase. Two radiologists with different levels of expertise independently assessed the presence of PE in the generated ED-Zeff maps, blinded to CECT results, which served as the reference standard. Diagnostic accuracy of ED-Zeff maps was assessed for each reader. Results: The final study cohort comprised 150 patients, with 92 males (mean age: 68 ± 10 years, range: 47-93 years) and 58 females (mean age: 66 ± 15 years, range 38-89 years). ED-Zeff maps demonstrated high diagnostic performance, yielding accuracy, sensitivity, and specificity, respectively, of 86.67% (113/150, 95% CI, 80.16%-91.66%), 85% (17/20, 95% CI, 79.89%-92.19%), and 86.92% (113/130, 95% CI, 79.89%-92.19%). Ed-Zeff maps were able to identify PE in 85% of positive cases. Cohen's kappa coefficient indicated excellent intra- and interobserver agreement (κ ≥ 0.9). Conclusion: ED maps combined with Zeff images from unenhanced dl-DECT scans represent a feasible tool for detecting PE and may prove useful in evaluating patients with contraindications to iodinated contrast.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.